JAKARTA: An Indonesia-based pharmaceutical company, PT Tempo Scan Pacific Tbk, booked 20.2% net income rise to IDR192 billion in the first quarter on increasing revenue.
In a press statement published today, the company said the sales figure grew by 8% to IDR1.31 trillion in the first three months ending March despite generally slower market growth for pharmaceutical as well as consumer products in the beginning of 2011.
Tempo Scan's operating income increased 17.1% in the first quarter 2011 to IDR207.1 billion, compared to the same period last year. Its operating income margin rose to 15.8% compared to 14.6% in the first quarter last year.
Furthermore, the company's net cash position as of March 31, 2011 was IDR1.34 trillion.
The TSPC-coded stock declined 1.12% or IDR25 to IDR2,200 at the Indonesia Stock Exchange as of 2.41 p.m. It shares were traded with a P/E ratio of 20.10. Its competitor was traded in different P/E ratio, for instance PT Kalbe Farma Tbk with P/E ratio of 23.96, PT Merck Tbk with 18.14, PT Darya Varia Laboratoria Tbk with 11.12, PT Kimia Farma Tbk with 7.34, and PT Indofarma Tbk with 21.71. (NOM)
--
Source: http://www.bisnis.com/business/25708-tempo-scan-records-202-hike-in-1q-net-income
~
Manage subscription | Powered by rssforward.com